Cargando…
Generation of Novel Immunocompetent Mouse Cell Lines to Model Experimental Metastasis of High-Risk Neuroblastoma
SIMPLE SUMMARY: Neuroblastoma (NB) is the most common extracranial solid pediatric cancer, with highly observed metastasis at diagnosis. Primary NBs generally have favorable outcomes with current therapies; however, high-risk, metastatic NBs are resistant and result in relapsed disease. Patients wit...
Autores principales: | Dhamdhere, Mayura R., Spiegelman, Dan V., Schneper, Lisa, Erbe, Amy K., Sondel, Paul M., Spiegelman, Vladimir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571844/ https://www.ncbi.nlm.nih.gov/pubmed/37835389 http://dx.doi.org/10.3390/cancers15194693 |
Ejemplares similares
-
Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
por: Biegel, Jason M., et al.
Publicado: (2021) -
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist
por: Pieper, Alexander A., et al.
Publicado: (2023) -
Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
por: Liu, Zhenqiu, et al.
Publicado: (2020) -
Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022) -
Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma
por: Koehn, Tony A., et al.
Publicado: (2012)